Charity Hastens Drug Development
April 25, 2006 | Read Time: 1 minute
An influx of charitable donations has spurred the development of drugs to fight overlooked diseases, such as malaria and tuberculosis, The Washington Post reports.
According to a new report by researchers from the London School of Economics and Political Science, leadership from the Bill & Melinda Gates Foundation, the Rockefeller Foundation, Doctors Without Borders, and other groups has improved the climate for working on diseases that disproportionately affect developing countries.
Unless poor countries, and the rich countries that support them, come up with a way to deliver the new drugs to needy people, however, that research could languish, the report said.
